Abstracts tagged "dermatomyositis"

Abstract Number: 1037 • 2012 ACR/ARHP Annual Meeting
Magnetic Resonance Imaging (MRI) Assessment of Inflammatory Myopathy: Quantitative Fat-Corrected Muscle T2 and Conventional T2 Measurement Versus Standard MRI and Clinical Metrics
Lawrence Yao¹, Adrienne L. Yip², Sepehr Mesdaghinia², Ashkan Shademan², Joseph A. Shrader³, Anna V. Jansen⁴, Frederick W. Miller⁴ and Lisa G. Rider⁴, ¹Diagnostic Radiology, NIH Clinical Center, Bethesda, MD, ²NIEHS, NIH, Bethesda, MD, ³Rehabilitation Medicine, Clinical Center, NIH, Bethesda, MD, ⁴Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD
Background/Purpose: Active muscle disease in patients with idiopathic inflammatory myopathies (IIM) is characterized by prolonged muscle T2 relaxation on MRI. We examined the utility of…
Abstract Number: 1041 • 2012 ACR/ARHP Annual Meeting
Whole-Body Magnetic Resonance Imaging – A New Diagnostic Tool in the Assessment of Activity in Juvenile Dermatomyositis Patients?
Tania Monteiro de Castro¹, Henrique Lederman¹, Maria Teresa Terreri², Wanda I. Caldana¹, Edmar Zanoteli³ and Maria Odete Hilario¹, ¹Federal University of São Paulo, São Paulo, Brazil, ²Universidade Federal de São Paulo/UNIFESP, São Paulo, Brazil, ³University of São Paulo, São Paulo, Brazil
Background/Purpose: Juvenile dermatomyositis (JDM) is a rare autoimmune disorder, but remains the most commonly chronic inflammatory myopathy among children. A redefinition of the diagnostic criteria…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].